Market Newsdesk

Former Curaleaf Chief Operating Officer brings significant industry knowledge and expertise to Agrify

BURLINGTON, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) — Agrify Corporation (NasdaqCM:AGFY) (“Agrify” or the “Company”) today announced the appointment of Stuart Wilcox, former Chief Operating Officer of Curaleaf, to its Board of Directors. Mr. Wilcox has replaced Matthew Kressy as an Independent Director on the Board. Mr. Kressy recently stepped down as a Director, but he will continue to engage with the Company by actively serving on Agrify’s Advisory Board.

Mr. Wilcox is a highly accomplished executive with over 30 years of domestic and international experience, including multiple leadership roles in the cannabis industry. During his career, he has served on numerous cannabis and biotech boards and teams. Mr. Wilcox is currently Chairman of the Board of Ora Pharm, an international cannabis company based in New Zealand. He is also a member of the Advisory Board for Revelation Micro and Managing Partner of NuRevelation, a biotech company based in North Carolina. Previously, Mr. Wilcox spent three years as the Chief Operating Officer of Curaleaf, during which time the company grew into one of the industry’s largest cannabis companies. Mr. Wilcox has been a strong advocate for cannabis, influencing legislation to require product safety certifications for cannabis operators, standardized product testing, and standard operating procedures.

“I am thrilled to welcome Stuart to Agrify’s Board of Directors,” said Raymond Chang, Chief Executive Officer and Chairman of the Board of Agrify. “Stuart brings a wealth of knowledge and experience in the cannabis industry from his previous roles that we believe will be invaluable to Agrify as we continue to scale up our organization to take on the significant growth opportunities ahead of us.”

“My experience in the industry has given me substantial insight into the market, and I believe Agrify has one of the most exciting new cultivation solutions available,” said Stuart Wilcox. “I am extremely impressed with the quality of the Vertical Farming Units as well as the seamless integration with the Agrify Insights platform. I strongly believe the turnkey solution Agrify provides customers will enable them to grow with new confidence and insights and drive their ability to produce high-quality flower consistently.”

Mr. Chang added, “On behalf of the whole Board, I would also like to thank Matthew for his service as a Director, and we look forward to working with him in his new role as an advisor to our team on product development and design.”

Mr. Wilcox’s previous work in the agriculture sector has included amassing the largest hydroponic grow operation for mung beans in the United States and developing hydroponic cultivation facilities for leafy greens. He received an undergraduate degree in Engineering from the University of Toledo and a graduate degree from Central Michigan University.

About Agrify (NasdaqCM:AGFY)
We are a developer of premium grow solutions for the indoor agriculture marketplace. We use data, science, and technology to empower our customers to be more efficient, more productive, and more intelligent about how they run their businesses. Our highly advanced and proprietary hardware and software solutions have been designed to help our customers achieve the highest quality, consistency, and yield, all at the lowest possible cost. For more information, please visit our website at www.agrify.com.

Forward-Looking Statements
This press release contains forward-looking statements that are made pursuant to the safe harbor provisions within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that may cause actual results or events to differ materially from those projected. These risks and uncertainties, many of which are beyond our control, include: risks relating to our growth strategy; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; risks relating to the results of development activities; our ability to attract, integrate and retain key personnel; our need for additional funds; intellectual property matters; competition; as well as other risks described in the section entitled “Risk Factors” in the prospectus from our initial public offering, which can be obtained on the SEC website at www.sec.gov. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date on which they are made and reflect management’s current estimates, projections, expectations, and beliefs. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions, or circumstances on which any such statement is based, except as required by law.

Company Contacts:

Agrify

Niv Krikov
Chief Financial Officer
[email protected]
(617) 896-5240

Rob Kelly
Investor Relations
[email protected]
(416) 992-4539 

TORONTO, Feb. 22, 2021 (GLOBE NEWSWIRE) — Gran Colombia Gold Corp. (TSX: GCM; OTCQX: TPRFF) (“Gran Colombia”) announced today that it has acquired 33,666,666 common shares (“Common Shares”) of Denarius Silver Corp. (formerly ESV Resources Ltd.) (“Denarius” or the “Issuer”) (TSX-V: DSLV) in connection with the completion of the Reverse Takeover Transaction, as more particularly described below.

Zancudo Transaction

On February 19, 2021, the Issuer completed a share purchase transaction (the “Zancudo Transaction”) with Gran Colombia pursuant to which the Issuer acquired certain mining assets (the “Zancudo Mining Assets”) located in the Municipalities of Titiribi, Angelopolis and Armenia, Department of Antioquia, Colombia. The Issuer acquired the Zancudo Mining Assets pursuant to a share purchase agreement dated November 20, 2020 among Gran Colombia, the Issuer, Gran Colombia Gold, S.A. (“GCG Panama”) and Gran Colombia Gold Titiribi Corp. (“GCG Titiribi”), whereby the Issuer purchased from GCG Panama, a wholly-owned subsidiary of Gran Colombia, of all of the issued and outstanding shares of GCG Titiribi, which holds title to all of the Zancudo Mining Assets through its Colombian branch, Gran Colombia Titiribi Sucursal Colombia. The Zancudo Mining Assets were acquired by the Issuer for CA$12,150,000 which was satisfied by the issuance by the Issuer to Gran Colombia of an aggregate of 27,000,000 common shares having a deemed price of CA$0.45 per common share.

Amalgamation Transaction

Concurrently with the completion of the Zancudo Transaction, on February 19, 2021 the Issuer completed a three-cornered amalgamation (the “Amalgamation Transaction”) with 1255269 B.C. Ltd. (“Guia Antigua Co.”) and 1270702 B.C. Ltd., pursuant to which the Issuer acquired certain mining assets (the “Guia Antigua Mining Assets”) indirectly owned by Guia Antigua Co. and located 130 kilometers northeast of Medellin in the Segovia-Remedios mining district, Department of Antioquia. The Amalgamation Transaction was completed pursuant to an amalgamation agreement dated November 20, 2020 (the “Amalgamation Agreement”), whereby the Issuer acquired Guia Antigua Co. in exchange for the issuance of an aggregate of 15,000,000 shares of the Issuer to the shareholders of Guia Antigua Co.

Prior to the completion of, and in connection with, the Amalgamation Transaction, Guia Antigua Co. completed a private placement offering (the “Private Placement”) on November 9, 2020 to raise aggregate proceeds of CA$8,403,774 through the sale of 18,675,053 subscription receipts (individually a “Subscription Receipt” and collectively, the “Subscription Receipts”) at a price of CA$0.45 per Subscription Receipt. Gran Colombia acquired 6,666,666 Subscription Receipts for total cost of approximately CA$3,000,000. Each Subscription Receipt automatically converted into one common share of Guia Antigua Co. immediately prior to completion of the Amalgamation Transaction. Upon satisfaction of the escrow release conditions in the Amalgamation Agreement, a total of 18,675,053 common shares of Guia Antigua Co. were issued to holders of Subscription Receipts and such common shares were subsequently exchanged for common shares of the Issuer in connection with the completion of the Reverse Takeover Transaction (as defined below).

Reverse Takeover Transaction

The concurrent completion of the Zancudo Transaction and the Amalgamation Transaction (collectively, the “Reverse Takeover Transaction”) constituted a reverse takeover under the policies of the TSX Venture Exchange (the “Exchange”). Upon the completion of the Reverse Takeover Transaction, the Issuer changed its name to “Denarius Silver Corp.” and will commence trading on the Exchange under the symbol “DSLV” on or about March 1, 2021. Upon completion of the Reverse Takeover Transaction, Denarius has 93,117,915 common shares issued and outstanding.

Following the completion of the Reverse Takeover Transaction, Gran Colombia has acquired a total of 33,666,666 common shares of Denarius. Prior to the Reverse Takeover Transaction, Gran Colombia did not hold any securities of Denarius. The common shares acquired by Gran Colombia represent approximately 36.15% of the issued and outstanding common shares of Denarius.

The common shares of Denarius acquired by Gran Colombia are presently being held only for investment purposes. Gran Colombia may from time to time in the future increase or decrease its ownership, control or direction over securities of Denarius held by it, through market transactions, private agreements or otherwise, the whole depending on market conditions, the business and prospects of Denarius and other relevant factors.

Gran Colombia has filed an early warning report (the “Early Warning Report”) pursuant to applicable securities laws in connection with the completion of the Reverse Takeover Transaction. A copy of the Early Warning Report, to which this news release relates, will be available under Denarius’ profile on SEDAR at www.sedar.com. To obtain a copy of the Early Warning Report, please contact Amanda Fullerton, Corporate Secretary, at Gran Colombia’s office at 401 Bay Street, Suite 2400, PO Box 15, Toronto, Ontario M5H 2Y4 or by calling (416) 360-4653.

About Gran Colombia Gold Corp.

Gran Colombia is a Canadian-based mid-tier gold producer with its primary focus in Colombia where it is currently the largest underground gold and silver producer with several mines in operation at its high-grade Segovia Operations. Gran Colombia owns approximately 44% of Aris Gold Corporation, a Canadian mining company currently advancing a major expansion and modernization of its underground mining operations at its Marmato Project in Colombia. Gran Colombia’s project pipeline also includes an approximately 18% equity interest in Gold X Mining Corp. (TSXV: GLDX) (Guyana – Toroparu), an approximately 36% equity interest in Denarius Silver Corp. (TSX-V: DSLV) (Colombia – Guia Antigua and Zancudo) and an approximately 26% equity interest in Western Atlas Resources Inc. (“Western Atlas”) (TSX-V: WA) (Nunavut – Meadowbank).

Additional information on Gran Colombia can be found on its website at

www.grancolombiagold.com

and by reviewing its profile on SEDAR at

www.sedar.com

.

Cautionary Statement on Forward-Looking Information:

This news release contains “forward-looking information”, which may include, but is not limited to, statements with respect to anticipated business plans or strategies. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, or “believes” or variations (including negative variations) of such words and phrases, or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Gran Colombia to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Factors that could cause actual results to differ materially from those anticipated in these forward-looking statements are described under the caption “Risk Factors” in the Company’s Annual Information Form dated as of March 30, 2020 which is available for view on SEDAR at www.sedar.com. Forward-looking statements contained herein are made as of the date of this press release and Gran Colombia disclaims, other than as required by law, any obligation to update any forward-looking statements whether as a result of new information, results, future events, circumstances, or if management’s estimates or opinions should change, or otherwise. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, the reader is cautioned not to place undue reliance on forward-looking statements.

For Further Information, contact:

Mike Davies
Chief Financial Officer
(416) 360-4653
[email protected]

Piraeus, Greece, Feb. 22, 2021 (GLOBE NEWSWIRE) — GasLog Partners LP (“GasLog Partners”) (NYSE: GLOP) announced today that its Board of Directors has called an annual meeting of limited partners to be held virtually on Thursday, May 13, 2021.

Unitholders of record at the close of business on Monday March 22, 2021 will be entitled to receive notice of, and to vote at, the annual meeting and at any adjournments or postponements thereof.

Formal notice of the meeting and GasLog Partners’ proxy statement will be sent to unitholders of GasLog Partners in due course.

Contacts:

Joseph Nelson 
Head of Investor Relations 
Phone: +1 212-223-0643 

Email: [email protected] 

About GasLog Partners

GasLog Partners is a growth-oriented owner, operator and acquirer of LNG carriers. The Partnership’s fleet consists of 15 LNG carriers with an average carrying capacity of approximately 158,000 cbm. GasLog Partners is a publicly traded master limited partnership (NYSE: GLOP) but has elected to be treated as a C corporation for U.S. income tax purposes and therefore its investors receive an Internal Revenue Service Form 1099 with respect to any distributions declared and received. The Partnership’s principal executive offices are located at 69 Akti Miaouli, 18537, Piraeus, Greece. Visit GasLog Partners’ website at http://www.gaslogmlp.com.

– All IN program to provide free advertising and creative services to Big Brothers Big Sisters, Blacbiblio.com, Canadian Women & Sport, Friends of Ruby, and Spirit North –

TORONTO, Feb. 22, 2021 (GLOBE NEWSWIRE) — A shoulder to lean on, resources to learn and prosper, and a support system that encourages self-confidence and empowerment are virtues in life that many take for granted, but not every Canadian can easily access.

Together in partnership with five Canadian charities and small businesses, Rogers Sports & Media today launches the inaugural year of its inclusion and diversity program All IN to support equity-seeking communities by amplifying stories on a national stage that haven’t always been heard with equal measure.  Through the Rogers Sports & Media megaphone, Big Brothers Big Sisters, Blacbiblio.com, Canadian Women & Sport, Friends of Ruby, and Spirit North will receive free advertising and creative services to support their efforts in uplifting underserved communities.

“Though these five organizations differ in their specific missions and the communities they serve, they each share a profound sense of hope for an equitable future,” said Jordan Banks, President, Rogers Sports & Media.  “All of the organizations have an unrelenting drive to create positive change that is extraordinarily inspiring, and that is precisely what led us to select them as our 2021 All IN partners.  We are grateful to collaborate alongside them to share their unique stories and values with more Canadians than ever before.”

Rogers Sports & Media received more than 550 submissions for the 2021 All IN program.  Because of the overwhelming response, an additional 10 organizations from the applicant pool that each support the Black community will be profiled across the company’s suite of assets.  These features will highlight the charities and small businesses, along with work being done in the community, all throughout February during Black History Month.  The organizations are BlackHealingTO, Jeffrey Tosh Art, KidsSwag, Lay Up Basketball, MFMG Cosmetics, Naij Hair, Nia Centre for the Arts, Oofii, Shayla’s Voice, and KinkyCurlyYaki.

Building on Rogers Sports & Media’s commitment to inclusion and diversity, an internal Content Advisory Council has been formed to ensure diversity of thought is at the forefront of all editorial content.  The 2022 application process for All IN will open later this year; visit www.AllInForEquity.ca for further details. 

All IN complements the robust inclusion and diversity program at Rogers, which is centred around delivering concrete actions.  Rogers is committed to working in partnership with communities to help meet critical needs of our residents and neighbours.  Community programs that support underserved and vulnerable Canadians include the Ted Rogers Community Grants, Ted Rogers Scholarships, and Connected for Success, a program that offers affordable Internet to bridge the digital divide.  During the pandemic, Rogers has provided thousands of devices and plans as digital lifelines to women’s shelters, and to youth organizations such as Big Brothers Big Sisters Canada to keep youth connected to mentors.  In partnership with Jays Care Foundation and Food Banks Canada, the company also provided nine million meals through donations and food hampers for food banks across the country as part of Step Up to the Plate.  This year, in honour of its 60^th birthday and as part of The 60 Project, the Rogers team stepped up with a record number of volunteer hours to help make Canada stronger, together.

Here are the 2021 All IN partners:

Big Brothers Big Sisters

Big Brothers Big Sisters is a national organization that provides life-changing mentorship programs to more than 40,000 children and youth each year. Strong mentorship relationships are critical to enabling the children in their programs to develop into well-rounded adults. Their work has proven to help break the cycles of violence, drug abuse, poverty, and inequality.

“On behalf of the young people and their families across the country that we support, Big Brothers Big Sisters (BBBS) is thrilled to be a part of the Rogers Sports & Media All IN program,” said Leanne Nicolle, President & CEO, Big Brothers Big Sisters of Toronto.  “With over 100 locations across Canada, BBBS Agencies are proudly supporting our Bigs who work with children and youth to develop the skills they will need to thrive and overcome adversity.  Rogers Sports & Media’s commitment to supporting equity-seeking communities such as ours will significantly increase the awareness for the essential work we do.”

Blacbiblio.com

Based in Montreal, Blacbiblio.com brings to life the personalities and events that are regularly omitted from the pages of textbooks.  These resources are available for teachers to create engaging and fun lessons for students in grades 4 and up.

“Blacbiblio.com is excited to have at its disposal the expertise of the All IN and Rogers Sports & Media teams,” said Dorothy Williams, Founder, Blacbiblio.com.  “Our company is proud because we know that the ABC’s of Canadian Black History Kit can have a strong positive impact on our youth.  All IN will help Blacbiblio.com to increase the public’s awareness about the benefits of teaching Canadian Black history in our schools.”

Canadian Women & Sport

Women and girls are greatly underrepresented and underserved in Canadian sport – as athletes, leaders, and decision makers.  Canadian Women & Sport is dedicated to creating an equitable and inclusive system that empowers women and girls within sport and through sport.

“It is time to reimagine sport.  While women and girls have what it takes to succeed in sport, including talent, drive, and determination, they must overcome extra barriers simply because they are women,” said Allison Sandmeyer-Graves, CEO, Canadian Women & Sport.  “Canadian Women & Sport works on behalf of all girls and women to create a sport system that is safe, welcoming and inclusive.  All IN will help Canadian Women & Sport reach parents, coaches, leaders, and fans across Canada, and motivate them to be part of the solution.  Together, we will change the game so that everyone wins.”

Friends of Ruby

Friends of Ruby provides unique, welcoming spaces with counselling, social programs, housing, and practical resources for LGBTQI2S youth (16-29).  They help more than 300 youth every year to lead healthier and safer lives.

“We want to ensure vulnerable LGBTQI2S youth receive the message that Friends of Ruby is here to support their mental health and wellbeing,” said Lucy Gallo, Director of Youth Services and Housing.  “The partnership with Rogers Sports & Media’s All IN program is instrumental in expanding our reach and increasing public awareness on youth needs, helping to eliminate challenges and systemic barriers that LGBTQI2S youth face in their lives.”

Spirit North

Spirit North empowers Indigenous youth to be unstoppable in sport, school, and life. Through the transformative power of sport and play, Spirit North helps youth improve their health and wellness, develop leadership skills, find their voice, and fulfill their promise.

“We are absolutely thrilled to have been selected for Rogers Sports & Media’s All IN program. This partnership will help Spirit North by giving us a chance to share our story with Canadians from coast to coast – raising awareness and resources which will, in turn, help us reach even more Indigenous children and youth with sport for social development programs designed to engage, empower, and inspire.  We couldn’t be happier or more excited to be partnering with Rogers Sports & Media for this project!,” said Beckie Scott, Founder and CEO, Spirit North.

About Rogers Sports & Media

Rogers Sports & Media is a diverse sports and content company that connects with more than 30 million Canadians each week.  The company’s multimedia offerings include 54 radio stations, 29 local TV stations, 23 conventional and specialty television stations, podcasts, digital and e-commerce websites, and sporting events.  Rogers Sports & Media delivers unique storytelling through its range of powerful brands: Citytv, OMNI Television, FX, TSC, 680 NEWS, 98.1 CHFI, KiSS, Breakfast Television, Cityline, CityNews, Sportsnet – Canada’s #1 sports network, and the Blue Jays – Canada’s only Major League Baseball team.  Rogers Sports & Media is a subsidiary of Rogers Communications Inc. (TSX, NYSE: RCI). Visit RogersSportsandMedia.com. 

Media Contact

Caitlin Decarie, Rogers Sports & Media, [email protected], 647-299-6733

CHESTERBROOK, Pa., Feb. 22, 2021 (GLOBE NEWSWIRE) — Trevena, Inc. (TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that it will present a corporate update at the 10^th Annual SVB Leerink Global Healthcare Conference on Friday, February 26, 2021 at 8:40 a.m. EST.

A link to the webcast will be available on the Events page of the Investors section on the Company’s website at www.trevena.com/investors/events-presentations/ir-calendar.

About Trevena

Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with CNS disorders. The Company has one approved product in the U.S., OLINVYK™ (oliceridine) injection, indicated in adults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate. The Company also has four novel and differentiated investigational drug candidates: TRV250 for the acute treatment of migraine, TRV734 for maintenance treatment of opioid use disorder, and TRV027 for acute lung injury / abnormal blood clotting in COVID-19 patients. The Company has also identified TRV045, a novel S1P receptor modulator that may offer a new, non-opioid approach to treating a variety of CNS disorders.

For more information, please visit www.Trevena.com.

Investor Contact:

Daniel Ferry
LifeSci Advisors
Phone: 617-430-7576
Email: [email protected]

Company Contact:

Bob Yoder, SVP and Chief Commercial Officer
Trevena, Inc.
Phone: 610-354-8840

NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today announced that its President and Chief Executive Officer, Christopher U. Missling, PhD, will join the panel, “Industry and Advocacy Collaborations ─ Making it a Win-Win”, at the National Institutes of Health (NIH) virtual Rare Disease Day® event on Monday, March 1^st at 11:35 a.m. EST. There will be a live Q&A following the panel discussion.

Rare Disease Day® takes place every year on the last day of February, with several international events extending into March. The event at the NIH is sponsored by the National Center for Advancing Translational Sciences and the NIH Clinical Center. Rare Disease Day® at NIH aims to raise awareness about rare diseases, challenges and research underway. The event brings together all stakeholders involved in advancing research and therapeutic development for rare diseases and includes patients, rare disease families, patient advocacy professionals, healthcare providers, academic researchers, members of the biopharmaceutical industry, and government representatives.

Rare Disease Day® at NIH will be held virtually on Monday, March 1^st, 2021, from 10:30 a.m. to 5:30 p.m. EST. This year’s event will feature interactive panel discussions, rare stories through TED-style talks and more. The event is free and open to the public, including patients, patient advocates, health care providers, researchers, trainees, students, industry representatives and government employees.

Click here to register or to learn more about the event.

About Rare Disease Day® at NIH

Rare Disease Day at NIH aims to raise awareness about rare diseases, the people they affect, and NIH research collaborations underway to address scientific challenges and to advance new treatments.
The goals of Rare Disease Day at NIH are to:

• Demonstrate the NIH commitment to helping people with rare diseases through research.
• Highlight NIH-supported rare diseases research and the development of diagnostics and treatments.
• Initiate a mutually beneficial dialogue among public and private researchers, patients, patient advocates and policymakers.
• Exchange the latest rare diseases information with stakeholders to advance research and therapeutic efforts.
• Put a face on rare diseases by sharing stories of patients, their families and their communities.

About Anavex Life Sciences Corp.

Anavex Life Sciences Corp. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, pain and various types of cancer. Anavex’s lead drug candidate, ANAVEX®2-73 (blarcamesine), recently completed successfully a Phase 2a clinical trial for Alzheimer’s disease and a Phase 2 proof-of-concept study in Parkinson’s disease dementia and a Phase 2 study in adult patients with Rett syndrome. ANAVEX®2-73 is an orally available drug candidate that restores cellular homeostasis by targeting sigma-1 and muscarinic receptors. Preclinical studies demonstrated its potential to halt and/or reverse the course of Alzheimer’s disease. ANAVEX®2-73 also exhibited anticonvulsant, anti-amnesic, neuroprotective and anti-depressant properties in animal models, indicating its potential to treat additional CNS disorders, including epilepsy. The Michael J. Fox Foundation for Parkinson’s Research previously awarded Anavex a research grant, which fully funded a preclinical study to develop ANAVEX®2-73 for the treatment of Parkinson’s disease. ANAVEX®3-71, which targets sigma-1 and muscarinic receptors, is a promising clinical stage drug candidate demonstrating disease-modifying activity against the major hallmarks of Alzheimer’s disease in transgenic (3xTg-AD) mice, including cognitive deficits, amyloid and tau pathologies. In preclinical trials, ANAVEX®3-71 has shown beneficial effects on mitochondrial dysfunction and neuroinflammation. Further information is available at www.anavex.com. You can also connect with the company on Twitter,Facebook and LinkedIn.

Forward-Looking Statements

Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties. Actual events or results may differ materially from those projected in any of such statements due to various factors, including the risks set forth in the Company’s most recent Annual Report on Form 10-K filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and Anavex Life Sciences Corp. undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.

For Further Information:

Anavex Life Sciences Corp.
Research & Business Development
Toll-free: 1-844-689-3939
Email: [email protected]

Investors:

Andrew J. Barwicki
Investor Relations
Tel: 516-662-9461
Email: [email protected]